Program
| Time | 14 May 2022 (Saturday) | |||
| 12:30-13:30 |
Boehringer Ingelheim Lunch Symposium
Chairpersons: Prof King-Loong Cheung and Prof David Siu |
|||
|
Fighting heart failure: what tactics and weapons do we have now?
– Prof Andrew Coats (Australia) |
||||
| 13:30-13:40 |
Welcoming and Opening Remarks
Prof Chak-Sing Lau, Department Chairperson, Department of Medicine, School of Clinical Medicine, The University of Hong Kong Dr Tony Ko, Chief Executive, Hospital Authority |
|||
| 13:40-14:10 |
David Todd Distinguished Lecture
Chairperson: Prof Chak-Sing Lau Mathematical modelling in medicine: case of COVID-19 – Prof Gabriel Leung
|
|||
| 14:10-15:25 |
Updates and Advances in Management of Cardiac Diseases
Chairpersons: Dr Jo Jo Hai and Dr Kai-Hang Yiu |
|||
|
14:10-14:35
|
Underusage of combination therapy for treating hypertension from the start: does it reflect therapeutic inertia?
– Prof Claudio Borghi (Italy) |
|||
|
14:35-15:00
|
Management of valvular heart disease – the new spectrum
– Dr Simon Lam |
|||
|
15:00-15:25
|
Heart failure with preserved ejection fraction – challenges in diagnosis and management
– Dr Jo Jo Hai |
|||
| 15:25-15:45 |
Break Time
|
|||
| 15:45-16:15 |
Richard Yu Lecture
Chairperson: Prof Richard Yu Who’s afraid of the big bad wolf? – Prof Chak-Sing Lau
|
|||
| 16:15-17:05 |
Balance in Immune Dysregulation
Chairpersons: Dr Philip Li and Dr Helen Tsang |
|||
|
16:15-16:40
|
Polymyalgia rheumatica (PMR) – a rheumatic disorder in elderly
– Dr Carmen Ho |
|||
|
16:40-17:05
|
Lessons from primary immunodeficiencies: caution with biologic therapies
– Dr Philip Li |
|||
| 17:05-18:20 |
Frontiers in Respiratory Medicine
Chairpersons: Dr Bing Lam and Dr David Lam |
|||
|
17:05-17:30
|
Continuous positive airway pressure therapy for obstructive sleep apnea: myths and truths
– Dr Macy Lui |
|||
|
17:30-17:55
|
Are we diagnosing all types of PF-ILD?
– Prof Luca Richeldi (Italy) |
|||
|
17:55-18:20
|
Lung cancer – a journey from early detection through diagnosis to management
– Dr David Lam |
|||
| 18:20-18:45 |
Optimal Care and Treatment of Hepatocellular Carcinoma Patients
Chairperson: Dr Roland Leung |
|||
|
18:20-18:45
|
One two three in advanced liver cancer
– Dr Thomas Yau |
|||
| Time | 15 May 2022 (Sunday) | ||||
| 09:00-10:00 |
Clinical Pearls in Medicine
Chairpersons: Dr Patrick Chiu and Dr Anthony Tam |
Interactive Workshop for Clinical Practices
Chairpersons: Dr Jacqueline Yuen and Mr Kenneth Yip |
|||
|
09:00-09:30
|
Interpreting CT coronary angiogram: what you need to know
– Dr Frankie Tam |
Prevention of colorectal cancer development
– Dr Michael Cheung & Ms Shetaal Kaur |
|||
|
09:30-10:00
|
Wiser use of antibiotics
– Dr Pak-Leung Ho |
Geriatrics front-door service in QMH
– Dr Yat-Fung Shea & Ms Hoi-Sze She |
|||
| 10:00-11:15 |
Latest Progress in the Management of Important Gastrointestinal and Liver Diseases
Chairpersons: Dr Michael Cheung and Dr Michael Ko |
||||
|
10:00-10:25
|
GERD management and appropriate PPI use
– Prof Michael Vaezi (United States) |
||||
|
10:25-10:50
|
Metabolic-associated fatty liver disease: redefinition and reinterpretation
– Prof Wai-Kay Seto |
||||
|
10:50-11:15
|
New treatment options for inflammatory bowel disease
– Prof Wai-Keung Leung |
||||
| 11:15-11:35 |
Break Time
|
||||
| 11:35-12:25 |
Advances in the Management of Thromboembolism and B-cell Lymphomas
Chairpersons: Prof Raymond Liang and Dr Harry Gill |
||||
|
11:35-12:00
|
Updates on the diagnosis and management of B-cell lymphomas
– Dr Thomas Chan |
||||
|
12:00-12:25
|
Updates on the management of venous thromboembolism
– Prof Eric Tse |
||||
| 12:25-13:25 |
Amgen Lunch Symposium
Chairpersons: Dr David Lui and Dr Tai-Pang Ip Treatment sequence in osteoporosis management: the timing of switching among therapies
– Prof Serge Ferrari (Switzerland) |
||||
| 13:25-14:40 |
Novel Therapeutics for Complications of Diabetes and Graves’ Disease
Chairpersons: Prof Kathryn Tan and Dr Paul Lee |
||||
|
13:25-13:50
|
Targeting inflammation and fibrosis in diabetic kidney disease
– Dr Elif Ekinci (Australia) |
||||
|
13:50-14:15
|
Overcoming the injection barrier to beat the disease process: breakthrough for GLP-1 agonist treatment in T2D
– Prof Michael Lean (United Kingdom) |
||||
|
14:15-14:40
|
Therapeutic advances in Graves’ orbitopathy: to combine, repurpose, and innovate
– Dr Alan Lee |
||||
| 14:40-15:55 |
Optimising Patient Care and Outcomes in Chronic Kidney Disease
Chairpersons: Dr Anthony Chan and Dr Desmond Yap |
||||
|
14:40-15:05
|
SGLT2-inhibitors for DKD and non-diabetic kidney disease
– Prof Sydney Tang |
||||
|
15:05-15:30
|
Rethink hyperkalemia in managing cardiorenal syndrome – what are the new approaches?
– Dr Andrew Frankel (United Kingdom) |
||||
|
15:30-15:55
|
Dialysis – long-term complications and outcomes
– Prof Wai-Kei Lo |
||||
| 15:55-16:15 |
Break Time
|
||||
| 16:15-17:30 |
Clinical Excellency for Important Neurological Disorders
Chairpersons: Dr Koon-Ho Chan and Dr Gary Lau |
||||
|
16:15-16:40
|
Refractory epilepsy – many stories to tell
– Dr Richard Chang |
||||
|
16:40-17:05
|
Updates on the management of myasthenia gravis
– Dr Jacky Lee |
||||
|
17:05-17:30
|
Migraine prevention: real world experience with anti-CGRPs
– Dr Patricia Pozo-Rosich (Spain) |
||||
| 17:30-18:20 |
Challenges of the COVID-19 Pandemic
Chairpersons: Prof Mary Ip and Dr Yu-Cho Woo |
||||
|
17:30-17:55
|
COVID-19 vaccine immunogenicity and implications
– Prof David Hui |
||||
|
17:55-18:20
|
COVID-19 booster vaccine effectiveness and antiviral treatment
– Prof Ivan Hung |
||||
| 18:20-18:25 |
Closing Remarks
Dr Koon-Ho Chan, Chairman, Organising Committee, 26th HKMF |
||||
Last updated: 11 May 2022